Oncology Adjudicating Progression in the Checkpoint Era: Pseudoprogression, Hyperprogression, and the Limits of Radiographic Reasoning in Advanced NSCLC Abstract Checkpoint inhibitor therapy ushered in a new era in understanding the response assessment in…
Oncology Cancer of Unknown Primary: Metastatic First tumor-The Biology of Metastasis Eclipses that of Origin The idea of cancer of unknown primary (CUP) being the orphan cancer that could be traced back to no parental…
Oncology Programming Immunity Against Pancreatic Cancer: Neoantigens, mRNA Vaccines, and the Limits of an Immunologically Cold Tumor Pancreatic ductal adenocarcinoma (PDAC) occupies a uniquely hostile position in the oncological landscape,…
Oncology Familiarity Breeds Not Merely Contempt but Diagnostic Complacency-Neoplastic Transformation in Chronic Osteomyelitis A wound that does not heal demands reconsideration. The patient presents with a decades-long history of lower…